Merrimack Pharmaceuticals Inc
MACKDelisted May 10, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001274792
Merrimack Pharmaceuticals Inc was delisted on May 10, 2024; its insiders filed their last Form 4 on Dec 28, 2023; 70 institutions reported holding it in 13F filings for Q1 2024, worth $137.1M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Merrimack Pharmaceuticals Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 63 | 67 | +4 |
| Shares | 8.47M | 9.31M | +840.9K (+9.9%) |
| Value | $104.4M | $124.9M | +$20.4M (+19.6%) |
New holders (11)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ADAR1 Capital Management, LLC | 549,418 | $7.37M | 3.30% |
| Rosalind Advisors, Inc. | 60,000 | $804.6K | 0.67% |
| Renaissance Technologies LLC | 48,900 | $656.0K | 0.00% |
| Two Sigma Investments, LP | 21,834 | $292.8K | 0.00% |
| Invesco Ltd. | 12,066 | $161.8K | 0.00% |
| Allspring Global Investments Holdings, LLC | 11,827 | $158.6K | 0.00% |
| STRS Ohio | 3,300 | $44.0K | 0.00% |
| AJOVista, LLC | 1,544 | $20.7K | 0.03% |
| Headlands Technologies LLC | 300 | $4.02K | 0.00% |
| The PNC Financial Services Group, Inc. | 8 | $107 | 0.00% |
| GAMMA Investing LLC | 2 | $27 | 0.00% |
Sold out (7)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Centiva Capital, LP | 187,803 | $2.32M |
| Fifth Lane Capital, LP | 10,929 | $134.4K |
| Mascoma Wealth Management LLC | 5,000 | $61.6K |
| Citadel Advisors LLC | 3,398 | $41.9K |
| Dorsey Wright & Associates | 1,933 | $23.8K |
| Webster Bank, N. A. | 1,527 | $18.8K |
| AdvisorNet Financial, Inc | 20 | $247 |